Ni J - Search Results

1

Cancer stem cells and signaling pathways in radioresistance.

Chang L, Graham P, Hao J, Ni J, Deng J, Bucci J, Malouf D, Gillatt D, Li Y. Chang L, et al. Among authors: ni j. Oncotarget. 2016 Mar 8;7(10):11002-17. doi: 10.18632/oncotarget.6760. Oncotarget. 2016. PMID: 26716904 Free PMC article. Review.

2

Role of the EpCAM (CD326) in prostate cancer metastasis and progression.

Ni J, Cozzi PJ, Duan W, Shigdar S, Graham PH, John KH, Li Y. Ni J, et al. Cancer Metastasis Rev. 2012 Dec;31(3-4):779-91. doi: 10.1007/s10555-012-9389-1. Cancer Metastasis Rev. 2012. PMID: 22718399 Review.

3

Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro.

Chao H, Wang L, Hao J, Ni J, Chang L, Graham PH, Kearsley JH, Li Y. Chao H, et al. Among authors: ni j. Cancer Lett. 2013 Feb 1;329(1):17-26. doi: 10.1016/j.canlet.2012.08.035. Epub 2012 Sep 18. Cancer Lett. 2013. PMID: 22995071

4

The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.

Deng J, Wang L, Chen H, Li L, Ma Y, Ni J, Li Y. Deng J, et al. Among authors: ni j. Cancer Metastasis Rev. 2013 Dec;32(3-4):535-51. doi: 10.1007/s10555-013-9423-y. Cancer Metastasis Rev. 2013. PMID: 23609751 Review.

5

Combination therapy with the histone deacetylase inhibitor LBH589 and radiation is an effective regimen for prostate cancer cells.

Xiao W, Graham PH, Hao J, Chang L, Ni J, Power CA, Dong Q, Kearsley JH, Li Y. Xiao W, et al. Among authors: ni j. PLoS One. 2013 Aug 26;8(8):e74253. doi: 10.1371/journal.pone.0074253. eCollection 2013. PLoS One. 2013. PMID: 23991216 Free PMC article.

6

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y. Ni J, et al. Int J Biochem Cell Biol. 2013 Dec;45(12):2736-48. doi: 10.1016/j.biocel.2013.09.008. Epub 2013 Sep 25. Int J Biochem Cell Biol. 2013. PMID: 24076216

7

CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.

Ni J, Cozzi PJ, Hao JL, Beretov J, Chang L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, Kearsley JH, Li Y. Ni J, et al. Prostate. 2014 May;74(6):602-17. doi: 10.1002/pros.22775. Epub 2014 Feb 12. Prostate. 2014. PMID: 24615685

8

Cancer stem cells in prostate cancer chemoresistance.

Ni J, Cozzi P, Hao J, Duan W, Graham P, Kearsley J, Li Y. Ni J, et al. Curr Cancer Drug Targets. 2014;14(3):225-40. doi: 10.2174/1568009614666140328152459. Curr Cancer Drug Targets. 2014. PMID: 24720286

9

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.

Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y. Chang L, et al. Among authors: ni j. Crit Rev Oncol Hematol. 2015 Dec;96(3):507-17. doi: 10.1016/j.critrevonc.2015.07.005. Epub 2015 Jul 18. Crit Rev Oncol Hematol. 2015. PMID: 26253360 Review.

10

Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique.

Ni J, Cozzi P, Hung TT, Hao J, Graham P, Li Y. Ni J, et al. Transl Oncol. 2016 Feb;9(1):41-45. doi: 10.1016/j.tranon.2015.11.011. Transl Oncol. 2016. PMID: 26947880 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,055 results

Search Page

Filters